Edition:
United States

IsoRay Inc (ISR.A)

ISR.A on American Stock Exchange

0.53USD
2:53pm EDT
Change (% chg)

$0.00 (+0.00%)
Prev Close
$0.53
Open
$0.53
Day's High
$0.54
Day's Low
$0.53
Volume
26,939
Avg. Vol
11,152
52-wk High
$0.70
52-wk Low
$0.48

Chart for

About

IsoRay, Inc. is a medical technology company. The Company, through its subsidiary, IsoRay Medical, Inc., develops, manufactures and sells isotope-based medical products and devices for the treatment of cancer and other malignant diseases. The Company is engaged in the production and sales of Cesium-131 (Cs-131) brachytherapy... (more)

Overall

Beta: 0.90
Market Cap(Mil.): $29.05
Shares Outstanding(Mil.): 55.02
Dividend: --
Yield (%): --

Financials

  Industry Sector
P/E (TTM): -- 89.64 16.86
EPS (TTM): -- -- --
ROI: -- 2.40 11.22
ROE: -- 3.29 15.09

BRIEF-Isoray Q4 loss per share $0.03

* Isoray announces fourth quarter fiscal 2017 revenue of $1.37 million, 22 pct fourth quarter-over-fourth quarter increase

Sep 28 2017

BRIEF-Isoray Inc's unit enters into consignment agreement

* Isoray says ‍on Aug 25, Isoray Medical, a unit of co, entered into a consignment agreement with Medikorpharma-Ural LLC - SEC filing​

Aug 31 2017

BRIEF-Isoray receives FDA response to application for Gammatile

* Isoray receives FDA response to 510(k) application for Gammatile

Jul 06 2017

BRIEF-IsoRay Q3 loss per share $0.02

* Isoray announces third quarter fiscal 2017 financial results

May 10 2017

Competitors

Earnings vs. Estimates